Assessing the Usability and Reliability of the Prototype Prosthesis Devices
MOTU++
MOTU++ - Studio Clinico Protesi
1 other identifier
interventional
8
1 country
1
Brief Summary
The aim of the present study is to verify the functionalitỳ, the degree of safety and the reliability of devices composed of an intelligent socket that allows the detection of biosignals and provides vibrotactile feedback and a prosthesis with active knee and ankle joints and a sensorised foot, for people with trans-femoral or trans-tibial amputation, which allows the optimisation of the gait cycle by providing active assistance at the knee and ankle joints according to the specific movement made by the user. The prototype devices are innovative in that they make it possible to optimise the benefits generated by the presence of actuated joints by exploiting the biosignals detected to ensure optimal functionalitỳ in the performance of activities̀ of daily living.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 2, 2024
CompletedFirst Posted
Study publicly available on registry
September 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 27, 2026
December 1, 2025
11 months
September 2, 2024
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (7)
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
baseline
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
day 1
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
day 2
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
day 3
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
day 4
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
day 5
Ad hoc check list for Adverse Event
questionnaire that evaluate the device feasibility of the prosthesis and description of any adverse events.
day 6
Secondary Outcomes (17)
Borg Scale
day 1
Borg Scale
day 2
Borg Scale
day 3
Borg Scale
day 4
Borg Scale
day 5
- +12 more secondary outcomes
Study Arms (1)
prosthetic group performs the entire protocol with the prosthesis prototype.
OTHERInterventions
These 3 sessions will commence only upon successful completion of the prosthesis safety and reliability tests conducted in the preceding sessions. For each module combination, a session will be conducted to assess motor performance through the acquisition of spatiotemporal parameters and energy efficiency parameters of gait. Motor performance will be evaluated using functional assessment tests and data will be recorded during the following activities: * parallel bar walking on flat ground * parallel bar walking on an inclined surface * treadmill walking with a safety harness * stair climbing/descending with a handrail * standing up and sitting down from a chair within parallel bars At the end of each session, satisfaction questionnaires (ad hoc questionnaire) will be completed. At the end of the experiment, a usability scale for the devices (ad hoc System Usability Scale) will be completed. Each session is expected to last approximately 2.5 hours.
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years;
- Lower limb amputation at the transfemoral or transtibial level;
- Functional medical classification: Level K3-K4 \[25\];
- Subjects wearing a prosthesis for at least 1 year (experienced wearers);
- Maximum body weight 100 kg.
You may not qualify if:
- Significant medical comorbidities: Presence of severe neurological disorders, cardiovascular diseases, uncontrolled diabetes/hypertension, or severe sensory deficits.
- Implanted cardiac devices: Individuals with implanted pacemakers or cardioverter-defibrillators.
- Cognitive impairment: Individuals with a Mini-Mental State Examination (MMSE) score less than 24, adjusted for age and education, indicating cognitive impairment that may compromise understanding of instructions and research participation.
- Severe depressive symptoms: Individuals with a Beck Depression Inventory-II (BDI-II) score less than 19, indicating clinically significant depression that may affect motivation and participation in the research.
- Severe anxiety symptoms: Individuals with a State-Trait Anxiety Inventory (STAI-Y) score less than 50, indicating clinically significant anxiety that may interfere with research participation.
- Inability or unwillingness to provide informed consent: Individuals who are unable to understand or provide informed consent to participate in the research, or who refuse to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Fondazione Don Carlo Gnocchi
Florence, FI, 50143, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2024
First Posted
September 27, 2024
Study Start
November 1, 2023
Primary Completion
October 1, 2024
Study Completion
December 31, 2025
Last Updated
March 27, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share